1. Home
  2. IMRN vs DLPN Comparison

IMRN vs DLPN Comparison

Compare IMRN & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • DLPN
  • Stock Information
  • Founded
  • IMRN 1994
  • DLPN 1996
  • Country
  • IMRN Australia
  • DLPN United States
  • Employees
  • IMRN N/A
  • DLPN N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • IMRN Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • IMRN 14.4M
  • DLPN 16.9M
  • IPO Year
  • IMRN N/A
  • DLPN N/A
  • Fundamental
  • Price
  • IMRN $2.20
  • DLPN $1.82
  • Analyst Decision
  • IMRN
  • DLPN Strong Buy
  • Analyst Count
  • IMRN 0
  • DLPN 1
  • Target Price
  • IMRN N/A
  • DLPN $5.00
  • AVG Volume (30 Days)
  • IMRN 95.9K
  • DLPN 78.8K
  • Earning Date
  • IMRN 08-29-2025
  • DLPN 11-13-2025
  • Dividend Yield
  • IMRN N/A
  • DLPN N/A
  • EPS Growth
  • IMRN N/A
  • DLPN N/A
  • EPS
  • IMRN N/A
  • DLPN N/A
  • Revenue
  • IMRN $4,777,422.00
  • DLPN $51,257,243.00
  • Revenue This Year
  • IMRN N/A
  • DLPN $9.05
  • Revenue Next Year
  • IMRN N/A
  • DLPN $15.42
  • P/E Ratio
  • IMRN N/A
  • DLPN N/A
  • Revenue Growth
  • IMRN 48.63
  • DLPN 4.84
  • 52 Week Low
  • IMRN $1.50
  • DLPN $0.75
  • 52 Week High
  • IMRN $2.48
  • DLPN $1.88
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 58.40
  • DLPN 70.07
  • Support Level
  • IMRN $2.09
  • DLPN $1.56
  • Resistance Level
  • IMRN $2.24
  • DLPN $1.68
  • Average True Range (ATR)
  • IMRN 0.14
  • DLPN 0.15
  • MACD
  • IMRN -0.01
  • DLPN 0.03
  • Stochastic Oscillator
  • IMRN 55.00
  • DLPN 88.91

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: